Dr. Katie King is the CEO of BioOrbit, a company building a pharmaceuticals factory in microgravity to revolutionise cancer treatment. BioOrbit aims to bring a paradigm shift to the administration route of cancer treatments. Much like diabetics self-inject with solutions of crystalline insulin, through crystallising antibodies in microgravity, subcutaneous derivatives of anticancer treatments can be formulated, enabling cancer sufferers to self-inject at home. She is a strong believer that science in a microgravity environment can be used to accelerate healthcare and drug development on Earth and recent...read more